Studies completed over the past year, funded through a Phase II NIH grant, show unprecedented removal rates of 1,2,3-Trichloropropane (TCP) and co-contaminants using Microvi’s cometabolism treatment technology.
Read More
Studies completed over the past year, funded through a Phase II NIH grant, show unprecedented removal rates of 1,2,3-Trichloropropane (TCP) and co-contaminants using Microvi’s cometabolism treatment technology.
Read More